Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifileucel in Advanced Soft Tissue Sarcoma
NCT07741877Phase 2Recruiting
- Sponsor
- Iovance Biotherapeutics
- Start
- Oct 2026
- Primary completion
- Sep 2033
- Countries
- 1
01
Overview
A Phase 2 trial of lifileucel in soft tissue sarcoma (STS), sponsored by Iovance Biotherapeutics. Started Oct 2026; status: recruiting.
02
Drugs
lifileucel
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT07741877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07741877.